These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1201080)

  • 1. Superoxide dismutase activities of blood platelets in trisomy 21.
    Sinet PM; Lavelle F; Michelson AM; Jerome H
    Biochem Biophys Res Commun; 1975 Dec; 67(3):904-9. PubMed ID: 1201080
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Gene dosage effect in trisomy 21.
    Benson PF
    Lancet; 1975 Mar; 1(7906):584. PubMed ID: 47069
    [No Abstract]   [Full Text] [Related]  

  • 3. [Increase of erythrocyte superoxide dismutase activity in trisomy for chromosome 21].
    Sinet PM; Allard D; Lejeune J; Jérôme H
    C R Acad Hebd Seances Acad Sci D; 1974 Jun; 278(25):3267-70. PubMed ID: 4214295
    [No Abstract]   [Full Text] [Related]  

  • 4. The estimation of red cell superoxide dismutase activity by pulse radiolysis in normal and trisomic 21 subjects.
    Gilles L; Ferradini C; Foos J; Pucheault J; Allard D; Sinet PM; Jerome H
    FEBS Lett; 1976 Oct; 69(1):55-8. PubMed ID: 136364
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of platelet alkaline phosphatase in normal subjects and in trisomy 21 Down's syndrome patients.
    Tangheroni W; Cao A; Lungarotti S; Coppa G; De Virgiliis S; Furbetta M
    Clin Chim Acta; 1971 Nov; 35(1):165-72. PubMed ID: 4331344
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Gene dosage effect in trisomy 21.
    Sinet PM; Allard D; Lejeune J; Jerome H
    Lancet; 1975 Feb; 1(7901):276. PubMed ID: 46417
    [No Abstract]   [Full Text] [Related]  

  • 7. [Superoxide dismutase activity in selected morphotic components of human peripheral blood].
    Grabowska B; Lipecka K; Daniszewska K
    Med Pr; 1987; 38(4):239-43. PubMed ID: 3695929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Partial trisomy 21 (21q21 - 21q22.2)].
    Poissonnier M; Saint-Paul B; Dutrillaux B; Chassaigne M; Gruyer P; de Blignières-Strouk G
    Ann Genet; 1976 Mar; 19(1):69-73. PubMed ID: 132130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Types of enzymatic overdosing in trisomy 21: erythrocytic superoxide dismutase-AJ and phosphoglucomutase.
    Prişcu R; Sichitiu S
    Humangenetik; 1975 Aug; 29(1):79-83. PubMed ID: 126209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The level of superoxide dismutase in erythrocytes of children with Down syndrome (trisomy G and unbalanced translocation G 21/22).
    Kedziora J; Jeske J; Witas H; Bartosz G; Leyko W
    Acta Biol Med Ger; 1977; 36(5-6):779-82. PubMed ID: 146388
    [No Abstract]   [Full Text] [Related]  

  • 11. Dismutase activity in translocation trisomy.
    Kedziora J; Bartosz G; Leyko W; Rozynkowa D
    Lancet; 1979 Jan; 1(8107):105. PubMed ID: 84109
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunoreactive Cu SOD and Mn SOD in the circulating blood cells from normal and trisomy 21 subjects.
    Baret A; Baeteman MA; Mattei JF; Michel P; Broussolle B; Giraud F
    Biochem Biophys Res Commun; 1981 Feb; 98(4):1035-43. PubMed ID: 6452879
    [No Abstract]   [Full Text] [Related]  

  • 13. [Significance of the type of chromosome aberrations and biochemical disorders for diagnosis of Down's syndrome and the phenotype of partial trisomy 21].
    Mikiel-Kostyra K; Czerski P; Bartosz G; Sito A; Leyka W
    Pediatr Pol; 1980 Jan; 55(1):23-32. PubMed ID: 6445053
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anomaly of serotonin fixation by blood platelets of trisomic 21 subjects. I. Study of the general characteristics of the fixation].
    Jérome H; Kamoun P
    Bull Soc Chim Biol (Paris); 1968; 50(4):907-21. PubMed ID: 5671597
    [No Abstract]   [Full Text] [Related]  

  • 15. Superoxide production and reducing activity in human platelets.
    Marcus AJ; Silk ST; Safier LB; Ullman HL
    J Clin Invest; 1977 Jan; 59(1):149-58. PubMed ID: 187622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cu-Zn superoxide dismutase activities in platelets from stable bronchial asthmatic patients.
    Kurosawa M; Kobayashi H; Nakano M
    Int Arch Allergy Immunol; 1993; 101(1):61-5. PubMed ID: 8388755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple method for evaluating platelet superoxide dismutase.
    Violi F; Iuliano L; Alessandri C; Ghiselli A; Balsano F
    Scand J Clin Lab Invest; 1985 Dec; 45(8):713-6. PubMed ID: 4081623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vitro effect of methylmercuric chloride on superoxide dismutase activity of pig platelets.
    Kostka B; Krajewska U; Lipecka K
    Pol J Pharmacol Pharm; 1989; 41(5):453-8. PubMed ID: 2641398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Superoxide dismutase activity in the platelets of myeloproliferative disorders and of hemolytic anemia with glutathione reductase deficiency (author's transl)].
    Kuramoto A; Kimura A; Fujimura K
    Nihon Ketsueki Gakkai Zasshi; 1979 Jun; 42(3):544-5. PubMed ID: 495014
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased superoxide dismutase activity in the glutathione reductase deficient platelet.
    Kimura A; Fujimura K; Kuramoto A
    Nihon Ketsueki Gakkai Zasshi; 1980 Aug; 43(4):749-52. PubMed ID: 7223339
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.